Keywords:
Морфология, коронар синдром, ишемия, миокард, стеноз, некробиоз, дистрофия.References
Zhang Y., Cao H., Jiang P., Tang H. Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention: A community-based study // Medicine (Baltimore). – 2018. – 97(8). – e9785.
Zhang Y., Liu Y., Liu H., Tang W.H. Exosomes: biogenesis, biologic function and clinical potential // Cell Biosci. – 2019. – 9. – P.19.
Zhang Y., Pfaffle R., Blankenstein O., Hildebrand P. Molecular mechanisms of non-familial hypercholesterolemia // J Mol Med (Berl). – 2020. – 98(9). – P.1241-1253.
Zhao Q.M., Feng T.T., Zhao X., et al. Use of cardioprotective medications among patients with coronary artery disease in China: Results from the improving Care for Cardiovascular Disease in China-coronary artery disease (CCC-CAD) study // J Am Heart Assoc. – 2019. – 8(17). – e011496.
Zheng Z., Jayaram R., Jiang L., et al. Perioperative Rosuvastatin in Cardiac Surgery // N Engl J Med. – 2016. – 374(18). – P.1744-1753.
Zhou J., Austin R.C. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms // Biofactors. – 2009. – 35(2). – P.120-129.
Zhou L., Niu J.M., Jiang H.K. An atherogenic diet promotes macrophage infiltration into the sinoatrial node of the murine heart // Int J Mol Med. – 2017. – 39(5). – P.1355-1360.
Zhou M., Ren H., Han J., et al. Inflammatory proteins are associated with severity of coronary artery disease in patients with non-ST-elevation myocardial infarction during high-sensitivity troponin era // J Thorac Dis. – 2020. – 12(4). – P.1343-1352.
Zhuang J., Peng W., Liu H., Lin Y., Huang W., Xu J. Coronary bifurcation treatments with the provisional strategy in the past decade: A pooled analysis of 1,404 patients // Medicine (Baltimore). – 2017. – 96(51). – e9251.
Ziegelstein R.C., Fauerbach J.A., Stevens S.S., Romanelli J., Richter D.P., Bush D.E. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction // Arch Intern Med. – 2000. – 160(12). – P.1818-1823.
Zwakenberg S.R., den Braver N.R., Engelen A.I.P., et al. Vitamin K intake and all-cause and cause specific mortality // Clin Nutr. – 2017. – 36(5). – P.1294-1300.
Wang X., Khalil R.A. Matrix Metalloproteinases, Vascular Remodeling, and vascular disease // Adv Pharmacol. – 2018. – 81. – P.241-330.
Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis // Arterioscler Thromb Vasc Biol. – 1995. – 15(5). – P.551-561
Winchester D.E., Pepine C.J. Angina treatments and prevention of cardiac events: an appraisal of the evidence // Eur Heart J Suppl. – 2015. – 17(Suppl G). – P.G10-G18.
Witztum J.L., Lichtman A.H. The influence of innate and adaptive immune responses on atherosclerosis // Annu Rev Pathol. – 2014. – 9. – P.73-102.
Wolf D., Ley K. Immunity and Inflammation in Atherosclerosis // Circ Res. – 2019. – 124(2). – P.315-327.
Wong N.D. Epidemiological studies of CHD and the evolution of preventive cardiology // Nat Rev Cardiol. – 2014. – 11(5). – P.276-289.
Yao X., Smolka G., Wawrzynska M., Franz N., Neunteufl T., Leung S.W. Interventional therapy for acute myocardial infarction: Primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention // Heart Lung Circ. – 2017. – 26(7). – P.748-755.